Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$709M |
| 2 |
Amazon
AMZN
|
+$653M |
| 3 |
Tesla
TSLA
|
+$457M |
| 4 |
Exxon Mobil
XOM
|
+$450M |
| 5 |
Uber
UBER
|
+$382M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$520M |
| 2 |
Netflix
NFLX
|
+$476M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$377M |
| 5 |
Apple
AAPL
|
+$374M |
Sector Composition
| 1 | Technology | 19.76% |
| 2 | Healthcare | 17.68% |
| 3 | Consumer Discretionary | 13.1% |
| 4 | Industrials | 7.95% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Turkcell
TKC
$4.86B
| $678K | ﹤0.01% |
141,050
+111,750
| +381% | +$537K |
|
2627
Daily Journal
DJCO
$562M
| $677K | ﹤0.01% |
1,987
+887
| +81% | +$302K |
|
2628
Ebang International Holdings
EBON
$28.1M
| $676K | ﹤0.01% |
44,213
| – | – |
|
2629
Comstock Holding Companies
CHCI
$173M
| $673K | ﹤0.01% |
151,782
-282
| -0.2% | -$1.25K |
|
2630
FinWise Bancorp
FINW
$261M
| $673K | ﹤0.01% |
47,000
+31,100
| +196% | +$445K |
|
2631
Similarweb
SMWB
$857M
| $672K | ﹤0.01% |
126,000
+90,100
| +251% | +$481K |
|
|
NAGE
2632
Niagen Bioscience, Inc. Common Stock
NAGE
$766M
| $671K | ﹤0.01% |
469,302
+24,390
| +5% | +$34.9K |
|
|
WKME
2633
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $670K | ﹤0.01% |
62,800
+41,500
| +195% | +$443K |
|
2634
Global X Artificial Intelligence & Technology ETF
AIQ
$4.89B
| $669K | ﹤0.01% |
+21,461
| New | +$669K |
|
2635
Five Point Holdings
FPH
$417M
| $666K | ﹤0.01% |
216,800
+135,100
| +165% | +$415K |
|
2636
Wolverine World Wide
WWW
$2.48B
| $666K | ﹤0.01% |
+74,900
| New | +$666K |
|
|
QXO
2637
QXO Inc
QXO
$14B
| $666K | ﹤0.01% |
4,863
+1,080
| +29% | +$148K |
|
2638
International Flavors & Fragrances
IFF
$16.8B
| $664K | ﹤0.01% |
+8,200
| New | +$664K |
|
2639
Smith-Midland
SMID
$211M
| $664K | ﹤0.01% |
+16,800
| New | +$664K |
|
2640
MicroSectors U.S. Big Oil 3x Leveraged ETNs due February 17, 2045
NRGU
$9.61M
| $663K | ﹤0.01% |
+1,600
| New | +$663K |
|
2641
Usio Inc
USIO
$40M
| $662K | ﹤0.01% |
385,141
+23,800
| +7% | +$40.9K |
|
2642
Schwab 5-10 Year Corporate Bond ETF
SCHI
$9.14B
| $661K | ﹤0.01% |
29,400
+12,400
| +73% | +$279K |
|
2643
Seadrill
SDRL
$2.04B
| $661K | ﹤0.01% |
13,979
-3,891
| -22% | -$184K |
|
2644
Stoneridge
SRI
$228M
| $660K | ﹤0.01% |
33,719
-4,400
| -12% | -$86.1K |
|
2645
Minerva Neurosciences
NERV
$15.2M
| $659K | ﹤0.01% |
107,200
+13,000
| +14% | +$79.9K |
|
2646
iShares ESG Aware MSCI EAFE ETF
ESGD
$10.1B
| $657K | ﹤0.01% |
+8,700
| New | +$657K |
|
2647
Chicago Rivet & Machine Co
CVR
$9.47M
| $656K | ﹤0.01% |
38,610
-500
| -1% | -$8.5K |
|
2648
Global X MLP & Energy Infrastructure ETF
MLPX
$2.6B
| $656K | ﹤0.01% |
14,700
+2,006
| +16% | +$89.5K |
|
|
MACK
2649
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $656K | ﹤0.01% |
+48,900
| New | +$656K |
|
|
CATC
2650
DELISTED
CAMBRIDGE BANCORP
CATC
| $655K | ﹤0.01% |
9,441
-2,480
| -21% | -$172K |
|